Early diagnosis is most important in AMD

There are nearly 190 million AMD patients worldwide. In Poland, according to the Retina AMD Association of Poland, there may be as many as 140,000 people with the exudative form of this progressive, multidimensional disabling disease. It is estimated that there will be up to 14 thousand new patients each year. Among the risk factors cited are age (over 50), race (white), gender (female), family history of AMD, and unhealthy lifestyles associated with smoking, physical inactivity or hypertension. The previous report was prepared in 2015. As the association's president, Malgorzata Pacholec, points out, a lot has changed in patient care over the past eight years.

- Since 2016, patients have been treated in the drug program. It's a fantastic program, which is the gold standard for treating patients with exudative AMD. So we have a very good standard of treatment. However, at the moment it treats at ...